eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
2/2014
vol. 39
 
Share:
Send email
Share:
abstract:

Clinical immunology
The effects of calcitriol with calcium carbonate supplementation on inflammatory biomarkers in chronic kidney disease patients’ with low vitamin D

Ruslinda BT Mustafar
,
Rozita Mohd
,
Norazinizah Ahmad Miswan
,
Arba’ayah Bain
,
Rizna Cader
,
Abdul Halim Abdul Gafor
,
Marlyn Mohammad
,
Shamsul Azhar Shah
,
Nor Azmi Kamaruddin
,
Norella CT Kong

(Centr Eur J Immunol 2014; 39 (2): 236–242)
DOI: https://doi.org/10.5114/ceji.2014.43729
Online publish date: 2014/06/27
View full text Get citation
 
PlumX metrics:
Introduction: Chronic kidney disease (CKD) patients’ are at risk of low vitamin D and chronic inflammation. We studied the effect of 12 weeks calcitriol and calcium carbonate supplementation on inflammatory mediators serum; interleukin-6 (IL-6), interleukin-10 (IL-10) and highly sensitive C-reactive protein (hs-CRP).

Material and methods: A prospective randomized study in CKD stages 2-4 with serum 25-hydroxyvitamin D (25-OHD) levels < 30 ng/ml. Patients were randomized into the Vitamin D + Calcium (Vitamin D+C) or Calcium group. Serums were analyzed at baseline, week 6 and 12.

Results: Fifty patients, median age of 53 (13.5) years were recruited. Their median IL-10 was 13.35 (25.22) pg/ml. At week 12, serum IL-6 was reduced in both groups (p = 0.001), serum IL-10 was maintained in the Vitamin D + C group (p = 0.06) and was reduced in the Calcium group (p = 0.001). CKD-diabetic patients had reduced serum IL-6 in both study groups (p = 0.001) and a reduction was seen in the Vitamin D + C group of the non-diabetics counterparts (p = 0.005). Serum IL-10 was reduced in the Calcium group (p < 0.05) whereas serum 25-OHD rose in both groups, regardless of their diabetic status (p < 0.05).

Conclusions: Twelve weeks, calcitriol supplementation maintained IL-10, had no effects on hs-CRP and had no additional benefit compared to calcium carbonate in reducing serum IL-6 except in non-diabetics.
keywords:

inflammation, vitamin D, diabetes, chronic kidney disease, calcitriol
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.